Summary:
Rappeport et al first reported the clinical syndrome of graft-versus-host disease (GVHD) in syngeneic bone marrow transplant patients. Recently, there have been more reports of a GVHD-like syndrome in syngeneic bone marrow transplant patients (SGVHD) that may result in significant clinical morbidity. A total of 17 cases of SGVHD in syngeneic bone marrow transplant patients have been reported to date in the medical literature. The current report reviews these cases and presents two additional cases of severe SGVHD that have occurred at our institution.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Billingham RE, Brent L . A simple method for inducing skin allograft in mice. Transplant Bull 1957; 4: 67.
Deeg HJ, Cottler-Fox M . Clinical spectrum and pathophysiology of graft-versus-host disease. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds). Graft-versus-host Disease: Immunology, Pathophysiology and Treatment. Marcel Dekker: New York, 1990, pp 311–336.
Hess AD, Horowitz L, Beschorner WE et al. Development of graft-versus-host disease like syndrome in cyclosporin-treated rats after syngeneic bone marrow transplant. J Exp Med 1985; 161: 718–730.
Einsele H, Ehninger G, Schneider EM et al. High frequency of graft versus host like syndromes following syngeneic bone marrow transplantation. Transplantation 1988; 45: 579–585.
Rappeport JM, Mihm M, Reinherz E et al. Acute graft-versus-host disease in recipients of bone marrow transplant from identical donors. Lancet 1979; ii: 717–720.
Gluckman E, Devergie A, Sohier J et al. Graft-versus-host disease in recipients of syngeneic bone marrow. Lancet 1980; i: 253–254.
Hood AF, Vogelsang GB, Black LP et al. Acute graft-versus-host disease, development following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987; 123: 745–750.
Deane M, Singer C, Lawler M et al. Acute skin GVHD following syngeneic BMT for CLL. Bone Marrow Transplant 1998; 22: 1207–1209.
Hwang WY, Goh YT, Tan CH et al. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy. Bone Marrow Transplant 2000; 25: 205–207.
Wolin MJ, Rigor RL . Acute graft-versus-host disease in a recipient of a twin blood cell transplant. Bone Marrow Transplant 1996; 17: 125–126.
Spaner D, Lowsky R, Fyles G et al. Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient. Transplantation 1998; 66: 1251–1253.
Billingham RE . The biology of graft-versus-host reaction. Harvey Lect 1966–67; 62: 21–78.
Ferrara JLM, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.
Sale GE, Lerner KG, Barker EA et al. The skin biopsy in the diagnosis of graft-versus-host disease in man. Am J Pathol 1977; 89: 621–636.
Glazier A, Tutschka PJ, Farmer ER et al. Graft-versus-host disease in cyclosporin A treated rats after syngeneic and autologous bone marrow transplant. J Exp Med 1983; 158: 1–8.
Gao EK, Lo D, Cheney RT et al. Abnormal differentiation of thymocytes in mice treated with cyclosporine A. Nature 1988; 336: 176.
Shi Y, Sahai BM, Green DR . Cyclosporine A inhibits activation-induced cell death in T cell hybridomas and thymocytes. Nature 1989; 339: 625.
Cheney RT, Sprent J . Capacity of cyclosporine to induce auto-graft-versus-host disease and impair intrathymic T cell differentiation. Transplant Proc 1985; 17: 528.
Ferrara J, Burakoff S . The pathophysiology of graft-versus-host disease in a murine bone marrow transplant model. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds). Graft-versus-host Disease: Immunology, Pathophysiology and Treatment. Marcel Dekker: New York, 1990, pp 9–29.
Sale GE, Shulman HM, Hackman RC . Pathophysiology of bone marrow transplantation. In: Forman SJ, Blume KG, Thomas Ed (eds). Pathology of Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, MA, 1994, p 189.
Biddeson WE, Shaw S, Nelson DL . Virus specificity of human influenza virus immune cytotoxic T cells. J Immunol 1979; 122: 660–664.
Drobyski W, Thibodeau S, Truitt RL et al. Third party mediated graft rejection and graft-versus-host disease after T cell depleted bone marrow transplant as demonstrated by hypervariable DNA probes and HLA DR polymorphism. Blood 1989; 74: 2285–2294.
Anderson KC, Weinstein HJ . Transfusion-associated graft-versus-host disease. N Engl J Med 1990; 323: 315–321.
Jones R, Vogelsang GB, Hess A et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; 1: 754–757.
Morris LE, Vogelsang GB, Bright E et al. Immune reconstitution in cyclosporine A induced autologous graft-versus-host disease. Blood 1992; 80 (Suppl 1): 534 (Abstr.).
Kennedy MJ . Induced autologous graft-versus-host disease for treatment of cancer. Cancer Treatment Rev 1994; 20: 97–103.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Latif, T., Pohlman, B., Kalaycio, M. et al. Syngeneic graft-versus-host disease: a report of two cases and literature review. Bone Marrow Transplant 32, 535–539 (2003). https://doi.org/10.1038/sj.bmt.1704171
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704171
Keywords
This article is cited by
-
Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases
Modern Pathology (2011)
-
A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT
Bone Marrow Transplantation (2010)
-
Role of SLAM-Associated Protein in the Pathogenesis of Autoimmune Diseases and Immunological Disorders
Archivum Immunologiae et Therapiae Experimentalis (2010)